The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAura Egy Regulatory News (AURA)

Share Price Information for Aura Egy (AURA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.263%)
Open: 9.75
High: 9.75
Low: 9.75
Prev. Close: 9.75
AURA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

17 Mar 2021 07:45

RNS Number : 5421S
Aura Energy Limited
17 March 2021
 

17 March 2021

 

 

AURA ENERGY LIMITED

("Aura" or the "Company")

Results of Annual General Meeting

 

The Company wishes to advise that all Resolutions contained in the Notice of Meeting were carried by poll with the exception of Resolution 2 on Conditional Spill.

 

In accordance with ASX Listing rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, the following link provides information in relation to the proxy votes received for each Resolution considered by Members of the Company at the Annual General Meeting held today.

 

http://www.rns-pdf.londonstockexchange.com/rns/5421S_1-2021-3-17.pdf

 

Resolution 1 required 75% approval to be passed. This threshold has been achieved and these resolutions passed.

 

 

Aura Energy Limited

Peter Reeve (CEO)

 

SP Angel Corporate Finance LLP

(Nominated Advisor and Joint Broker)

Ewan Leggat

Caroline Rowe

 

WH Ireland Limited

(Joint Broker)

Adrian Hadden

James Sinclair-Ford

 

 

Yellow Jersey PR Limited

Felicity Winkles

Joe Burgess

 

Telephone: +61 (3) 9516 6500

info@auraenergy.com.au

 

Telephone: +44 (0) 203 470 0470

 

 

 

 

 

Telephone: +44 (0) 207 220 1666

 

 

 

 

 

Telephone: +44 (0) 7769 325 254

 

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

Martin Rogers - Non-Executive Chairman

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Martin Frederick Rogers, aged 40:

 Current directorships and/or partnerships:

Former directorships and/or partnerships (within the last five years):

 

KTM Ventures Innovation Fund LP

SpringCapital

Bitcoin Access

 

Independent Reserve

Identitii

Actinogen Medical

OncoSil Medical

 

 

As at the date of this announcement, Mr. Rogers does not hold any shares in the Company although following the issue of shares and options as proposed and passed at the AGM, Mr. Rogers will hold 50,000,000 shares on a pre-Consolidation basis, or 3,846,554 shares on a post-Consolidation basis. Mr. Rogers will also hold 200,000,000 options on a pre-Consolidation basis, or 15,384,616 options on a post-Consolidation basis.

These options will be exercisable at A$0.004 each on a pre-Consolidation basis, or A$0.052 each (on a post-Consolidation basis), on or before 30 June 2024.

Peter Ward - Non-Executive Director

 The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Peter Daniel Ward, aged 51:

No current directorships or previous directorships within the last five years are held by Mr. Ward.

As at the date of this announcement, Mr. Ward holds 3,000,000 shares in the Company although following the issue of shares and options as proposed and passed at the AGM, Mr. Ward will hold 28,000,000 shares on a pre-Consolidation basis, or 2,153,846 shares on a post-Consolidation basis. Mr. Ward will also hold 75,000,000 options on a pre-Consolidation basis, or 5,769,230 options on a post-Consolidation basis.

These options will be exercisable at A$0.004 each on a pre-Consolidation basis, or A$0.052 each (on a post-Consolidation basis), on or before 30 June 2024.

There are no further disclosures required under Schedule 2(g) of the AIM Rules for Companies. 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGDKOBQOBKKNND
Date   Source Headline
30th Oct 20204:36 pmRNSPrice Monitoring Extension
28th Oct 20208:05 amRNSASX Review
5th Oct 202011:00 amRNSC$4.5m Gold Funding Transaction Update
30th Sep 20209:49 amRNSPreliminary results for year ended 30 June 2020
2nd Sep 20202:06 pmRNSSecond Price Monitoring Extn
2nd Sep 20202:00 pmRNSPrice Monitoring Extension
2nd Sep 202011:03 amRNSL1 Capital Convertible Security
21st Aug 20201:16 pmRNSAura executes Loan Funding
17th Aug 20207:00 amRNSResult of General Meeting
13th Aug 20207:40 amRNSGeneral Meeting to Proceed
10th Aug 20202:00 pmRNSUpdate on gold funding transaction
10th Aug 20207:11 amRNSDocuments filed with Supreme Court of Victoria
31st Jul 202011:57 amRNSJune 2020 Quarterly Report
30th Jul 20204:41 pmRNSSecond Price Monitoring Extn
30th Jul 20204:36 pmRNSPrice Monitoring Extension
30th Jul 20202:05 pmRNSSecond Price Monitoring Extn
30th Jul 20202:00 pmRNSPrice Monitoring Extension
30th Jul 202011:05 amRNSSecond Price Monitoring Extn
30th Jul 202011:00 amRNSPrice Monitoring Extension
30th Jul 20209:06 amRNSSecond Price Monitoring Extn
30th Jul 20209:00 amRNSPrice Monitoring Extension
24th Jul 202012:37 pmRNSUpdate on General Meeting
23rd Jul 20203:49 pmRNSNotice of GM
16th Jul 20208:50 amRNSPeter Reeve interview re:Tasiast Gold Transaction
7th Jul 20208:00 amRNSAura signs C$4.5m gold funding deal term sheet
2nd Jul 20208:17 amRNSDirectorship update
19th Jun 20202:48 pmRNSNotice of intention to remove Directors at a GM
1st Jun 20209:04 amRNSUpdate on Australian Takeover Panel application
21st May 20207:29 amRNSResult of General Meeting
20th May 20209:45 amRNSUpdate on ASX Trading Halt
18th May 20208:16 amRNSIssue of Shares
18th May 20207:23 amRNSTrading Halt
15th May 20207:36 amRNSIssue of Shares
14th May 20207:39 amRNSIssue of Shares
11th May 20207:30 amRNSIssue of Shares
11th May 20207:00 amRNSBoard appointments
30th Apr 20209:31 amRNSMarch 2020 Quarterly Report
28th Apr 20207:00 amRNSIssue of Shares
27th Apr 20207:00 amRNSIssue of Shares
21st Apr 20207:30 amRNSEGM Update
20th Apr 202010:38 amRNSIssue of Shares
8th Apr 20207:00 amRNSIssue of Shares
26th Mar 20207:00 amRNSEGM Postponed
18th Mar 20207:00 amRNSIssue of Shares
17th Mar 20207:00 amRNSNotice of GM
13th Mar 20207:00 amRNSHalf-year Report
9th Mar 20207:00 amRNSIssue of Shares
6th Mar 20207:00 amRNSIssue of Shares
4th Mar 20208:00 amRNSBackground to Board Change requests
24th Feb 20207:00 amRNSRequisition Meeting of Shareholders

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.